Ozempic (semaglutide) injection is a glucagon-like peptide-1 (GLP-1) receptor agonist originally approved for the treatment of type 2 diabetes
Because of this careful introduction and the time it takes for the medication to build up in your system, significant weight loss is not expected during the initial week
For non-urgent but persistent palpitations, arrange a routine GP appointment for clinical assessment
Other ingredients: vegetable cellulose (capsule), acacia fiber, guar fiber, rosemary extract, microcrystalline cellulose, silica
Memory support supplement
These tend to be patients with higher baseline weight, who do not significantly compensate with increased eating, and who combine the medication with dietary changes